Preliminary antitumor activity of BAY 43–9006 in metastatic renal cell carcinoma and other advanced refractory solid tumors in a phase II randomized discontinuation trial (RDT)

Mark J. Ratain, K. T. Flaherty, Walter M. Stadler, P. O’Dwyer, Stan B. Kaye

DOI: 10.1200/jco.2004.22.14_suppl.4501

Journal of Clinical Oncology

Data up to Jan 2025

Published2004

Citations111

References0

Fields

Medicine Internal medicine Oncology Gastroenterology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Preliminary antitumor activity of BAY 43–9006 in metastatic renal cell carcinoma and… (2004) – Journal of Clinical Oncology | Metascience Observatory Explorer